WD Rutherford’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,714
| Closed | -$338K | – | 73 |
|
|
2024
Q3 | $338K | Sell |
1,714
-11,914
| -87% | -$2.35M | 0.16% | 68 |
|
|
2024
Q2 | $2.82M | Sell |
13,628
-936
| -6% | -$193K | 1.41% | 31 |
|
|
2024
Q1 | $3.95M | Sell |
14,564
-155
| -1% | -$42K | 2.04% | 17 |
|
|
2023
Q4 | $3.18M | Sell |
14,719
-680
| -4% | -$147K | 1.85% | 24 |
|
|
2023
Q3 | $3.02M | Buy |
15,399
+9,361
| +155% | +$1.83M | 2.07% | 19 |
|
|
2023
Q2 | $1.27M | Buy |
6,038
+40
| +0.7% | +$8.41K | 0.81% | 38 |
|
|
2023
Q1 | $1.21M | Sell |
5,998
-5
| -0.1% | -$1.01K | 0.85% | 38 |
|
|
2022
Q4 | $1.31M | Sell |
6,003
-75
| -1% | -$16.3K | 1.03% | 35 |
|
|
2022
Q3 | $1.2M | Sell |
6,078
-140
| -2% | -$27.5K | 0.96% | 39 |
|
|
2022
Q2 | $1.33M | Buy |
6,218
+125
| +2% | +$26.7K | 1.03% | 37 |
|
|
2022
Q1 | $1.73M | Buy |
6,093
+115
| +2% | +$32.7K | 0.99% | 39 |
|
|
2021
Q4 | $2.25M | Sell |
5,978
-72
| -1% | -$27.1K | 1.14% | 35 |
|
|
2021
Q3 | $2.5M | Buy |
6,050
+45
| +0.7% | +$18.6K | 1.36% | 32 |
|
|
2021
Q2 | $2.22M | Buy |
6,005
+145
| +2% | +$53.6K | 1.24% | 35 |
|
|
2021
Q1 | $1.7M | Buy |
5,860
+1,420
| +32% | +$411K | 1.06% | 38 |
|
|
2020
Q4 | $1.11M | Buy |
+4,440
| New | +$1.11M | 0.7% | 43 |
|